Daewoong running into anti-cancer drug markets

Published: 2006-09-08 06:58:00

Updated: 2006-09-08 06:58:00

Daewoong announced the anti-cancer drug business projects on Aug. 9, covering that until 2010 the company targeted to get 100 billion won of sales from the anti-cancer drug markets by realizing 3 subjects, namely, a differentiated product portfolio, a product design specialized for the domestic m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK